We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Swiftsure International Inc (CE) | USOTC:HLMB | OTCMarkets | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.0325 | 0.00 | 01:00:00 |
From Jun 2019 to Jun 2024
SCOTTSDALE, ARIZONA announces that it has completed a significant working capital financing. The Company can now continue its fantastic growth in sales throughout 2008.
Holmes Biopharma's clinical research subsidiary, Qualia Clinical Services Inc., will finish 2007 with sales of approximately $10 million. Management estimates that sales in 2008 will exceed $20 million, with clinics in Omaha, Nebraska, Toronto, Canada and Kiev, Ukraine operating at full capacity.
Holmes Biopharma's strategy for 2008 includes entering the drug development business with a significant acquisition targeted for early in the new year.
About Holmes:
Holmes Biopharma, Inc. is a contract research organization focused on providing integrated and cost effective clinical development services to the pharmaceutical industry. Currently, clinics operate in Omaha, Nebraska, USA, Toronto, Canada and Kiev, Ukraine. For more information about the company please visit our website at www.holmesbiopharma.com.
On behalf of the Board of Directors
John F. Metcalfe, President, CEO
Certain statements in this press release constitute "forward looking statements" within the meaning of the United States Securities Legislation. The Company's actual results could differ from those in the forward-looking statements. Do not construe this information as investment advice. This is not a solicitation to buy or sell securities. This does not purport to be a complete analysis of the Company. Investing in securities is speculative and carries a high degree of risk. Past performance does not guarantee future results. Readers should consult their own independent advisers with any investment, including any contemplated investment. All information contained in this press release should be independently investigated. This press release contains forward-looking statements. These remarks involve risks and uncertainties. Risks are not limited to quarterly fluctuations in results or the companies' management of growth and competition. Other risks are detailed in the Company's SEC filings. Actual results may differ materially from such information set forth herein.
Contacts: Holmes Biopharma, Inc. John Metcalfe 1-800-778-4990 Email: ir@holmesbiopharma.com Website: www.holmesbiopharma.com
1 Year Swiftsure (CE) Chart |
1 Month Swiftsure (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
